Epoch Investment Partners Inc. Sells 32,805 Shares of HCA Healthcare, Inc. $HCA

Epoch Investment Partners Inc. lessened its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 6.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 472,739 shares of the company’s stock after selling 32,805 shares during the quarter. HCA Healthcare makes up about 1.2% of Epoch Investment Partners Inc.’s portfolio, making the stock its 10th biggest holding. Epoch Investment Partners Inc.’s holdings in HCA Healthcare were worth $220,703,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Eschler Asset Management LLP acquired a new position in shares of HCA Healthcare during the 4th quarter valued at about $892,000. Barclays PLC boosted its position in shares of HCA Healthcare by 5.8% during the 4th quarter. Barclays PLC now owns 1,322,211 shares of the company’s stock valued at $617,287,000 after acquiring an additional 72,219 shares during the last quarter. Brown Advisory Inc. boosted its position in shares of HCA Healthcare by 168.4% during the 4th quarter. Brown Advisory Inc. now owns 15,887 shares of the company’s stock valued at $7,417,000 after acquiring an additional 9,967 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its position in shares of HCA Healthcare by 11.9% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock valued at $1,078,966,000 after acquiring an additional 245,887 shares during the last quarter. Finally, Atlas Capital Advisors Inc. acquired a new position in shares of HCA Healthcare during the 4th quarter valued at about $2,511,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $387.25 on Friday. The firm has a market capitalization of $85.91 billion, a PE ratio of 13.32, a price-to-earnings-growth ratio of 1.23 and a beta of 1.12. The firm’s 50-day moving average is $429.60 and its two-hundred day moving average is $473.48. HCA Healthcare, Inc. has a 1 year low of $330.00 and a 1 year high of $556.52.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The business had revenue of $19.11 billion for the quarter, compared to analysts’ expectations of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm’s revenue for the quarter was up 4.3% on a year-over-year basis. During the same quarter last year, the company earned $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts expect that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be paid a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is presently 10.73%.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on HCA shares. Cantor Fitzgerald restated an “overweight” rating on shares of HCA Healthcare in a report on Wednesday, March 4th. UBS Group boosted their price objective on shares of HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a report on Monday, February 23rd. Robert W. Baird reduced their price objective on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. Sanford C. Bernstein reduced their price objective on shares of HCA Healthcare from $503.00 to $413.00 and set a “market perform” rating on the stock in a report on Thursday, June 4th. Finally, JPMorgan Chase & Co. reduced their price objective on shares of HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating on the stock in a report on Tuesday, May 19th. Fifteen research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $506.14.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.